Neutrophil-dependent cutaneous side-effects of leucocyte colony-stimulating factors: Manifestations of a neutrophil recovery syndrome? [13]

British Journal of Dermatology

Volumn 150, Issue 6, 2004, Pages 1228-1230

  Dereure, O ^a   Hillaire Buys, D ^a   Guilhou, J J ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG INDICATION; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LETTER; MALE; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; NEUTROPHILIC DERMATOSIS; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; NEUTROPHILS; SKIN; SWEET'S SYNDROME;

EID: 3142768908     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06007.x     Document Type: Letter

References (13)

1. von der Driesch P. Sweet's syndrome. J Am Acad Dermatol 1994; 31: 535-56.
2. Roujeau JC. Neutrophilic drug eruptions. Clin Dermatol 2000; 18: 331-7.
3. Ross HJ, Moy LA, Kaplan R, Figlin RA. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991; 68: 441-3.
4. Park JW, Mehrotra B, Barnett BO et al. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 1992; 116: 996-8.
5. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994; 130: 77-81.
6. van Kamp H, van den Berg E, Timens W et al. Sweet's syndrome in myeloid malignancy: a report of two cases. Br J Haematol 1994; 86: 415-17.
7. Richard MA, Grob JJ, Laurans R et al. Sweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia. J Am Acad Dermatol 1996; 35: 629-31.
8. Lewerin C, Mobacken H, Nilsson-Ehle H, Swolin B. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy. Leuk Lymphoma 1997; 26: 629-32.
9. Levi I, Raanani P, Shalmon B et al. Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia. Leuk Lymphoma 1999; 34: 401-4.
10. Aractingi S, Mallet V, Pinquier L et al. Neutrophilic dermatoses during granulocytopenia. Arch Dermatol 1995; 131: 1141-5.
11. Spiekermann K, Roesler J, Emmendoerffer A et al. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 1997; 11: 466-78.
12. Johnston B, Kubes P. The α4-integrin: an alternative pathway for neutrophil recruitment? Immunol Today 1999; 20: 545-50.
13. Reuss-Borst MA, Pawelec G, Saal JG et al. Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol 1993; 84: 356-8.